Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,363 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Management of tracheostomy in COVID-19 patients: The Japanese experience.
Yokokawa T, Ariizumi Y, Hiramatsu M, Kato Y, Endo K, Obata K, Kawashima K, Sakata T, Hirano S, Nakashima T, Sekine T, Kiyuna A, Uemura S, Okubo K, Sugimoto T, Tateya I, Fujimoto Y, Horii A, Kimura Y, Hyodo M, Homma A. Yokokawa T, et al. Among authors: kawashima k. Auris Nasus Larynx. 2021 Jun;48(3):525-529. doi: 10.1016/j.anl.2021.01.006. Epub 2021 Jan 9. Auris Nasus Larynx. 2021. PMID: 33446370 Free PMC article.
COVID-19 findings revealed via otolaryngological examination: Findings of a Japan Otorhinolaryngologist Association questionnaire.
Kimura Y, Nogami K, Watanabe K, Yoshimura T, Asai H, Fujioka O, Kawasaki Y, Igarashi M, Inamura N, Kawashima K, Nishino H, Fukuyo K. Kimura Y, et al. Among authors: kawashima k. Auris Nasus Larynx. 2021 Dec;48(6):1176-1180. doi: 10.1016/j.anl.2021.05.010. Epub 2021 Jun 9. Auris Nasus Larynx. 2021. PMID: 34172351 Free PMC article.
Factors significantly associated with COVID-19 severity in symptomatic patients: A retrospective single-center study.
Hirashima T, Arai T, Kitajima H, Tamura Y, Yamada T, Hashimoto S, Morishita H, Minamoto S, Kawashima K, Kashiwa Y, Kameda M, Takeshita T, Suzuki H, Matsuoka H, Yamaguchi S, Tanaka T, Nagai T. Hirashima T, et al. Among authors: kawashima k. J Infect Chemother. 2021 Jan;27(1):76-82. doi: 10.1016/j.jiac.2020.09.022. Epub 2020 Oct 10. J Infect Chemother. 2021. PMID: 33051144 Free PMC article.
The clinical features of intractable allergic rhinitis based on a questionnaire administered to clinicians.
Imoto Y, Sakashita M, Hayama M, Nakamaru Y, Suzuki M, Miyabe Y, Yamada T, Saito H, Yonekura S, Kondo K, Higaki T, Kawashima K, Urashima M, Fujieda S. Imoto Y, et al. Among authors: kawashima k. Allergol Int. 2021 Jul;70(3):373-375. doi: 10.1016/j.alit.2020.12.003. Epub 2021 Feb 25. Allergol Int. 2021. PMID: 33642145 Free article. No abstract available.
[SUBLINGUAL IMMUNOTHERAPY].
Kawashima K. Kawashima K. Arerugi. 2022;71(2):92-101. doi: 10.15036/arerugi.71.92. Arerugi. 2022. PMID: 35296609 Japanese. No abstract available.
Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet.
Gotoh M, Okubo K, Yuta A, Ogawa Y, Nagakura H, Ueyama S, Ueyama T, Kawashima K, Yamamoto M, Fujieda S, Sakashita M, Sakamoto H, Iwasaki N, Mori E, Endo T, Ohta N, Kitazawa H, Okano M, Asako M, Takada M, Terada T, Inaka Y, Yonekura S, Matsuoka T, Kaneko S, Hata H, Hijikata N, Tanaka H, Masuyama K, Okamoto Y. Gotoh M, et al. Among authors: kawashima k. Allergol Int. 2020 Jan;69(1):104-110. doi: 10.1016/j.alit.2019.07.007. Epub 2019 Aug 14. Allergol Int. 2020. PMID: 31421989 Free article. Clinical Trial.
1,363 results